Page 479 - 16Neonatal Jaundice_compressed
P. 479

Neonatal jaundice


 Bibliographic   Study Type &   Number of   Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes   Comments
 Information   Evidence Level   Patients/Characteristics   (E:C)   (Mean:SD: N)
 1992   Not reported   Babies with Rh antigens born  Phototherapy +  IVIG  500 mg/kg body   No adverse effects were   protocol violations
       to mothers lacking Rh   weight over 2 hours   noted
 Country:   Randomisation:   antigens,
 Germany   Not reported   Positive Coombs’ test

 207
 ID:     Evidence level:   Exclusion:
 1 -   Not reported

 Demographics:
 Gender (M/F): Not reported
 Mean GA: Not reported
 Mean BW: Not reported
 Age at entry to study: Not
 reported
 Mean TSB: Not reported
 Author:   Methodology:   N:   Group 1:   Exchange transfusion:   Max TSB:
 Dagoglu T   RCT   41   Phototherapy   Group 1: 15/19   Group 1: 224 ± 99 micromol/litre
             Group 2: 4/22
 Year:   Blinding:   Inclusion:   Group 2:      Group 2: 198 ± 106 micromol/litre
 1995   None   Babies with Rh antigens born  Phototherapy + IVIG 500 mg/kg body
       to mothers lacking Rh   weight as soon as possible after birth
 Country:   Randomisation:   antigens,
 Turkey   Random numbers   Positive Coombs’ test
    table with sealed
 208
 ID:     envelopes   Exclusion:
    Not reported
 Evidence level:
 1 ++   Demographics:
     Gender (M/F): 25/16
 Mean GA: 36.1 ± 2.0 weeks
 Mean BW: 2776 ± 419 g
 Age at entry to study: Not
 reported
 Mean TSB: Not reported
 Author:   Methodology:   N:   Group 1:   Exchange transfusion:   Mean duration of treatment:
 Nasseri F   RCT   34   Phototherapy   Group 1: 11/17   Group 1: 154 ± 48 hours
             Group 2: 3/17
 Year:   Blinding:   Inclusion:   Group 2:      Group 2: 119 ± 23 hours
 2006   Not reported   Gestation age > 37 weeks,   Phototherapy + IVIG   No adverse effects were
       Positive Coombs’ test,      noted
 Country:   Randomisation:   Significant   IVIG (500 mg/kg body weight) was given
 Iran   Not reported   hyperbilirubinaemia rising at  with 2–4 hours of admission for 3
       8.5micromol/litre per hour,   consecutive doses each 12 hours
 209
 ID:     Evidence level:   TsB below exchange
 1 -   transfusion levels,

 Exclusion:


 312
   474   475   476   477   478   479   480   481   482   483   484